drugset / Trial / NCT02499029

N-acetylcysteine in the Treatment of PTSD and Addiction

NCT02499029 ↗

Phase 2 Completed 35 enrolled Medical University of South Carolina
RandomizedFactorialQuadruple-blindTreatment

Summary

Examine the effects of N-acetylcysteine on PTSD symptoms, craving and substance use in veterans with PTSD and comorbid substance use disorders.

Timeline

Start
2013-02
Primary completion
2014-09
Completion
2014-09

Outcome

Met primary endpoint

paper Participants treated with N-acetylcysteine compared to placebo evidenced significant improvements in PTSD symptoms, craving, and depression (β values < -0.33; P values < .05). PMID 27736051 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 1200 mg —